{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:18:22Z","timestamp":1791206302227,"version":"4.1.0"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"23","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,12,1]]},"DOI":"10.1093\/hmg\/ddi405","type":"journal-article","created":{"date-parts":[[2005,10,26]],"date-time":"2005-10-26T20:13:08Z","timestamp":1130357588000},"page":"3751-3757","source":"Crossref","is-referenced-by-count":97,"title":["TAB2, TRAF6 and TAK1 are involved in NF-\u03baB activation induced by the TNF-receptor, Edar and its adaptator Edaradd"],"prefix":"10.1093","volume":"14","author":[{"given":"Aurore","family":"Morlon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold","family":"Munnich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Smahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2005,10,26]]},"reference":[{"key":"key\n\t\t\t\t20171012093727_DDI405C1","doi-asserted-by":"crossref","unstructured":"Kumar, A., Takada, Y., Boriek, A.M. and Aggarwal, B.B. (2004) Nuclear factor-kappaB: its role in health and disease. J. Mol. Med., 82, 434\u2013448.","DOI":"10.1007\/s00109-004-0555-y"},{"key":"key\n\t\t\t\t20171012093727_DDI405C2","doi-asserted-by":"crossref","unstructured":"Sonenshein, G.E. (1997) Rel\/NF-kappa B transcription factors and the control of apoptosis. Semin. Cancer Biol., 8, 113\u2013119.","DOI":"10.1006\/scbi.1997.0062"},{"key":"key\n\t\t\t\t20171012093727_DDI405C3","doi-asserted-by":"crossref","unstructured":"Li, Q. and Verma, I.M. (2002) NF-kappaB regulation in the immune system. Nat. Rev. Immunol., 2, 725\u2013734.","DOI":"10.1038\/nri910"},{"key":"key\n\t\t\t\t20171012093727_DDI405C4","doi-asserted-by":"crossref","unstructured":"Lin, A. and Karin, M. (2003) NF-kappaB in cancer: a marked target. Semin. Cancer Biol., 13, 107\u2013114.","DOI":"10.1016\/S1044-579X(02)00128-1"},{"key":"key\n\t\t\t\t20171012093727_DDI405C5","doi-asserted-by":"crossref","unstructured":"Aradhya, S. and Nelson, D.L. (2001) NF-kappaB signaling and human disease. Curr. Opin. Genet. Dev., 11, 300\u2013306.","DOI":"10.1016\/S0959-437X(00)00194-5"},{"key":"key\n\t\t\t\t20171012093727_DDI405C6","doi-asserted-by":"crossref","unstructured":"Kumar, A., Eby, M.T., Sinha, S., Jasmin, A. and Chaudhary, P.M. (2001) The ectodermal dysplasia receptor activates the nuclear factor-kappaB, JNK, and cell death pathways and binds to ectodysplasin A. J. Biol. Chem., 276, 2668\u20132677.","DOI":"10.1074\/jbc.M008356200"},{"key":"key\n\t\t\t\t20171012093727_DDI405C7","doi-asserted-by":"crossref","unstructured":"Doffinger, R., Smahi, A., Bessia, C., Geissmann, F., Feinberg, J., Durandy, A., Bodemer, C., Kenwrick, S., Dupuis-Girod, S., Blanche, S. et\u00a0al. (2001) X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat. Genet., 27, 277\u2013285.","DOI":"10.1038\/85837"},{"key":"key\n\t\t\t\t20171012093727_DDI405C8","doi-asserted-by":"crossref","unstructured":"Headon, D.J., Emmal, S.A., Ferguson, B.M., Tucker, A.S., Justice, M.J., Sharpe, P.T., Zonana, J. and Overbeek, P.A. (2001) Gene defect in ectodermal dysplasia implicates a death domain adapter in development. Nature, 414, 913\u2013916.","DOI":"10.1038\/414913a"},{"key":"key\n\t\t\t\t20171012093727_DDI405C9","doi-asserted-by":"crossref","unstructured":"Yan, M., Zhang, Z., Brady, J.R., Schilbach, S., Fairbrother, W.J. and Dixit, V.M. (2002) Identification of a novel death domain-containing adaptor molecule for ectodysplasin-A receptor that is mutated in crinkled mice. Curr. Biol., 12, 409\u2013413.","DOI":"10.1016\/S0960-9822(02)00687-5"},{"key":"key\n\t\t\t\t20171012093727_DDI405C10","doi-asserted-by":"crossref","unstructured":"Thesleff, I. and Mikkola, M.L. (2002) Death receptor signaling giving life to ectodermal organs. Sci. STKE, 2002, PE22.","DOI":"10.1126\/stke.2002.131.pe22"},{"key":"key\n\t\t\t\t20171012093727_DDI405C11","doi-asserted-by":"crossref","unstructured":"Mikkola, M.L. and Thesleff, I. (2003) Ectodysplasin signaling in development. Cytokine Growth Factor Rev., 14, 211\u2013224.","DOI":"10.1016\/S1359-6101(03)00020-0"},{"key":"key\n\t\t\t\t20171012093727_DDI405C12","doi-asserted-by":"crossref","unstructured":"Ferguson, B.M., Brockdorff, N., Formstone, E., Ngyuen, T., Kronmiller, J.E. and Zonana, J. (1997) Cloning of Tabby, the murine homolog of the human EDA gene: evidence for a membrane-associated protein with a short collagenous domain. Hum. Mol. Genet., 6, 1589\u20131594.","DOI":"10.1093\/hmg\/6.9.1589"},{"key":"key\n\t\t\t\t20171012093727_DDI405C13","doi-asserted-by":"crossref","unstructured":"Kere, J., Srivastava, A.K., Montonen, O., Zonana, J., Thomas, N., Ferguson, B., Munoz, F., Morgan, D., Clarke, A., Baybayan, P. et\u00a0al. (1996) X-linked anhidrotic (hypohidrotic) ectodermal dysplasia is caused by mutation in a novel transmembrane protein. Nat. Genet., 13, 409\u2013416.","DOI":"10.1038\/ng0895-409"},{"key":"key\n\t\t\t\t20171012093727_DDI405C14","doi-asserted-by":"crossref","unstructured":"Monreal, A.W., Ferguson, B.M., Headon, D.J., Street, S.L., Overbeek, P.A. and Zonana, J. (1999) Mutations in the human homologue of mouse dl cause autosomal recessive and dominant hypohidrotic ectodermal dysplasia. Nat. Genet., 22, 366\u2013369.","DOI":"10.1038\/11937"},{"key":"key\n\t\t\t\t20171012093727_DDI405C15","doi-asserted-by":"crossref","unstructured":"Srivastava, A.K., Pispa, J., Hartung, A.J., Du, Y., Ezer, S., Jenks, T., Shimada, T., Pekkanen, M., Mikkola, M.L., Ko, M.S. et\u00a0al. (1997) The Tabby phenotype is caused by mutation in a mouse homologue of the EDA gene that reveals novel mouse and human exons and encodes a protein (ectodysplasin-A) with collagenous domains. Proc. Natl Acad. Sci. USA, 94, 13069\u201313074.","DOI":"10.1073\/pnas.94.24.13069"},{"key":"key\n\t\t\t\t20171012093727_DDI405C16","doi-asserted-by":"crossref","unstructured":"Zonana, J., Elder, M.E., Schneider, L.C., Orlow, S.J., Moss, C., Golabi, M., Shapira, S.K., Farndon, P.A., Wara, D.W., Emmal, S.A. et\u00a0al. (2000) A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO). Am. J. Hum. Genet., 67, 1555\u20131562.","DOI":"10.1086\/316914"},{"key":"key\n\t\t\t\t20171012093727_DDI405C17","doi-asserted-by":"crossref","unstructured":"Smahi, A., Courtois, G., Vabres, P., Yamaoka, S., Heuertz, S., Munnich, A., Israel, A., Heiss, N.S., Klauck, S.M., Kioschis, P. et\u00a0al. (2000) Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium. Nature, 405, 466\u2013472.","DOI":"10.1038\/35013114"},{"key":"key\n\t\t\t\t20171012093727_DDI405C18","doi-asserted-by":"crossref","unstructured":"Aradhya, S., Courtois, G., Rajkovic, A., Lewis, R.A., Levy, M., Israel, A. and Nelson, D.L. (2001) Atypical forms of incontinentia pigmenti in male individuals result from mutations of a cytosine tract in exon 10 of NEMO (IKK-gamma). Am. J. Hum. Genet., 68, 765\u2013771.","DOI":"10.1086\/318806"},{"key":"key\n\t\t\t\t20171012093727_DDI405C19","doi-asserted-by":"crossref","unstructured":"Courtois, G., Smahi, A., Reichenbach, J., Doffinger, R., Cancrini, C., Bonnet, M., Puel, A., Chable-Bessia, C., Yamaoka, S., Feinberg, J. et\u00a0al. (2003) A hypermorphic IkappaBalpha mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency. J. Clin. Invest., 112, 1108\u20131115.","DOI":"10.1172\/JCI18714"},{"key":"key\n\t\t\t\t20171012093727_DDI405C20","doi-asserted-by":"crossref","unstructured":"Jain, A., Ma, C.A., Liu, S., Brown, M., Cohen, J. and Strober, W. (2001) Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia. Nat. Immunol., 2, 223\u2013228.","DOI":"10.1038\/85277"},{"key":"key\n\t\t\t\t20171012093727_DDI405C21","doi-asserted-by":"crossref","unstructured":"Mansour, S., Woffendin, H., Mitton, S., Jeffery, I., Jakins, T., Kenwrick, S. and Murday, V.A. (2001) Incontinentia pigmenti in a surviving male is accompanied by hypohidrotic ectodermal dysplasia and recurrent infection. Am. J. Med. Genet., 99, 172\u2013177.","DOI":"10.1002\/1096-8628(2001)9999:9999<::AID-AJMG1155>3.0.CO;2-Y"},{"key":"key\n\t\t\t\t20171012093727_DDI405C22","doi-asserted-by":"crossref","unstructured":"Dupuis-Girod, S., Corradini, N., Hadj-Rabia, S., Fournet, J.C., Faivre, L., Le Deist, F., Durand, P., Doffinger, R., Smahi, A., Israel, A. et\u00a0al. (2002) Osteopetrosis, lymphedema, anhidrotic ectodermal dysplasia, and immunodeficiency in a boy and incontinentia pigmenti in his mother. Pediatrics, 109, e97.","DOI":"10.1542\/peds.109.6.e97"},{"key":"key\n\t\t\t\t20171012093727_DDI405C23","doi-asserted-by":"crossref","unstructured":"Takaesu, G., Kishida, S., Hiyama, A., Yamaguchi, K., Shibuya, H., Irie, K., Ninomiya-Tsuji, J. and Matsumoto, K. (2000) TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway. Mol. Cell, 5, 649\u2013658.","DOI":"10.1016\/S1097-2765(00)80244-0"},{"key":"key\n\t\t\t\t20171012093727_DDI405C24","doi-asserted-by":"crossref","unstructured":"Wang, C., Deng, L., Hong, M., Akkaraju, G.R., Inoue, J. and Chen, Z.J. (2001) TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature, 412, 346\u2013351.","DOI":"10.1038\/35085597"},{"key":"key\n\t\t\t\t20171012093727_DDI405C25","doi-asserted-by":"crossref","unstructured":"Naito, A., Yoshida, H., Nishioka, E., Satoh, M., Azuma, S., Yamamoto, T., Nishikawa, S. and Inoue, J. (2002) TRAF6-deficient mice display hypohidrotic ectodermal dysplasia. Proc. Natl Acad. Sci. USA, 99, 8766\u20138771.","DOI":"10.1073\/pnas.132636999"},{"key":"key\n\t\t\t\t20171012093727_DDI405C26","doi-asserted-by":"crossref","unstructured":"Cao, Z., Xiong, J., Takeuchi, M., Kurama, T. and Goeddel, D.V. (1996) TRAF6 is a signal transducer for interleukin-1. Nature, 383, 443\u2013446.","DOI":"10.1038\/383443a0"},{"key":"key\n\t\t\t\t20171012093727_DDI405C27","doi-asserted-by":"crossref","unstructured":"Smahi, A., Courtois, G., Rabia, S.H., Doffinger, R., Bodemer, C., Munnich, A., Casanova, J.L. and Israel, A. (2002) The NF-kappaB signalling pathway in human diseases: from incontinentia pigmenti to ectodermal dysplasias and immune-deficiency syndromes. Hum. Mol. Genet., 11, 2371\u20132375.","DOI":"10.1093\/hmg\/11.20.2371"},{"key":"key\n\t\t\t\t20171012093727_DDI405C28","doi-asserted-by":"crossref","unstructured":"Jono, H., Lim, J.H., Chen, L.F., Xu, H., Trompouki, E., Pan, Z.K., Mosialos, G. and Li, J.D. (2004) NF-kappaB is essential for induction of CYLD, the negative regulator of NF-kappaB: evidence for a novel inducible autoregulatory feedback pathway. J. Biol. Chem., 279, 36171\u201336174.","DOI":"10.1074\/jbc.M406638200"},{"key":"key\n\t\t\t\t20171012093727_DDI405C29","doi-asserted-by":"crossref","unstructured":"Trompouki, E., Hatzivassiliou, E., Tsichritzis, T., Farmer, H., Ashworth, A. and Mosialos, G. (2003) CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members. Nature, 424, 793\u2013796.","DOI":"10.1038\/nature01803"},{"key":"key\n\t\t\t\t20171012093727_DDI405C30","doi-asserted-by":"crossref","unstructured":"Brummelkamp, T.R., Nijman, S.M., Dirac, A.M. and Bernards, R. (2003) Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB. Nature, 424, 797\u2013801.","DOI":"10.1038\/nature01811"},{"key":"key\n\t\t\t\t20171012093727_DDI405C31","doi-asserted-by":"crossref","unstructured":"Kovalenko, A., Chable-Bessia, C., Cantarella, G., Israel, A., Wallach, D. and Courtois, G. (2003) The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination. Nature, 424, 801\u2013805.","DOI":"10.1038\/nature01802"},{"key":"key\n\t\t\t\t20171012093727_DDI405C32","doi-asserted-by":"crossref","unstructured":"Ling, L., Cao, Z. and Goeddel, D.V. (1998) NF-kappaB-inducing kinase activates IKK-alpha by phosphorylation of Ser-176. Proc. Natl Acad. Sci. USA, 95, 3792\u20133797.","DOI":"10.1073\/pnas.95.7.3792"},{"key":"key\n\t\t\t\t20171012093727_DDI405C33","doi-asserted-by":"crossref","unstructured":"Malinin, N.L., Boldin, M.P., Kovalenko, A.V. and Wallach, D. (1997) MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1. Nature, 385, 540\u2013544.","DOI":"10.1038\/385540a0"}],"container-title":["Human Molecular Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/hmg\/article-pdf\/14\/23\/3751\/1490186\/ddi405.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T10:03:05Z","timestamp":1507802585000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/hmg\/article\/14\/23\/3751\/559489\/TAB2-TRAF6-and-TAK1-are-involved-in-NF\u03baB"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10,26]]},"references-count":33,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2005,10,26]]},"published-print":{"date-parts":[[2005,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/hmg\/ddi405","relation":{},"ISSN":["1460-2083","0964-6906"],"issn-type":[{"value":"1460-2083","type":"electronic"},{"value":"0964-6906","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,12,1]]},"published":{"date-parts":[[2005,10,26]]}}}